Journal articles on the topic 'NF-kB activity'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'NF-kB activity.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Amin, Jakia, Ken-ichiro Otsuyama, Abul Islam, Karim Shamsasenjan, Shamim Mohd Iqbal, and Michio M. Kawano. "The Mechanism of Constitutive NF-kB Activity in Myeloma Cell Lines." Blood 110, no. 11 (November 16, 2007): 4740. http://dx.doi.org/10.1182/blood.v110.11.4740.4740.
Full textGhosh, Sankar, Eijiro Jimi, Jie Dong, and Haihong Zhong. "REGULATION OF NF-KB TRANSCRIPTIONAL ACTIVITY." Shock 21, Supplement (March 2004): 44. http://dx.doi.org/10.1097/00024382-200403001-00176.
Full textOtsuyama, Ken-ichiro, Jakia Amin, Saeid Abroun, Abul Islam, Karim Shamsasenjan, Shamim Mohd Iqbal, and Michio M. Kawano. "The PPARß Activation Mechanism Which Suppresses the Constitutive NF-kB Activity in Human Myeloma Cell Lines." Blood 110, no. 11 (November 16, 2007): 4739. http://dx.doi.org/10.1182/blood.v110.11.4739.4739.
Full textMagrangeas, Florence, Philippe Moreau, Loic Campion, Herve Avet-Loiseau, Catherine Guérin, Wilfried Gouraud, Gérald Marit, et al. "Low Level Of NF-Kb Activity Is Associated With Higher Response Rate To Bortezomib-Based Induction Therapy In Patients With Newly Diagnosed Multiple Myeloma." Blood 122, no. 21 (November 15, 2013): 3106. http://dx.doi.org/10.1182/blood.v122.21.3106.3106.
Full textTsai, Hui-Jen, Seiichiro Kobayashi, Kiyoko Itoh, Takaomi Ishida, Kazuo Umezawa, and Arinobu Tojo. "Microenvironmental Up-Regulation of NF-kB Activity Via P65-Dependent and Independent Pathways in a Bioimaging Model of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia." Blood 110, no. 11 (November 16, 2007): 723. http://dx.doi.org/10.1182/blood.v110.11.723.723.
Full textBao, Xiaoyong, Deepthi Kolli, Tianshuang Liu, Yichu Shan, Roberto P. Garofalo, and Antonella Casola. "Human Metapneumovirus Small Hydrophobic Protein Inhibits NF-κB Transcriptional Activity." Journal of Virology 82, no. 16 (June 11, 2008): 8224–29. http://dx.doi.org/10.1128/jvi.02584-07.
Full textWang, Xianhuo, Huaqing Wang, Chengfeng Bi, Xiaoyan Zhang, Xin Huang, Xuan Zhang, Javeed Iqbal, et al. "Microrna-17~92 Cluster Upregulates NF-KB Activity Via Suppressing Multiple NF-KB Negative Regulators Mediating Ubiquitination." Blood 126, no. 23 (December 3, 2015): 3638. http://dx.doi.org/10.1182/blood.v126.23.3638.3638.
Full textVassiliev, P. M., A. A. Spasov, L. R. Yanaliyeva, A. N. Kochetkov, V. V. Vorfolomeyeva, V. G. Klochkov, and D. T. Appazova. "Neural network modeling of multitarget RAGE inhibitory activity." Biomeditsinskaya Khimiya 65, no. 2 (2019): 91–98. http://dx.doi.org/10.18097/pbmc20196502091.
Full textNeumann, Manfred, and Michael Naumann. "Beyond IκBs: alternative regulation of NF‐KB activity." FASEB Journal 21, no. 11 (April 12, 2007): 2642–54. http://dx.doi.org/10.1096/fj.06-7615rev.
Full textNakagawa, Masahiro, Munetake Shimabe, Nahoko Nishimoto, Naoko Watanabe-Okochi, Motoshi Ichikawa, Yasuhito Nannya, Yoichi Imai, and Mineo Kurokawa. "AML1/Runx1 Is a Cytoplasmic Attenuator of NF-Kb Signaling: Implication in Pathogenesis and Targeted Therapy of AML1-Related Leukemia." Blood 114, no. 22 (November 20, 2009): 1962. http://dx.doi.org/10.1182/blood.v114.22.1962.1962.
Full textHussain, Sajjad, and Paul J. Galardy. "UCH-L1 Provides An Essential Survival Signal in Malignant B-Cells by Enhancing NF-κB Activation." Blood 112, no. 11 (November 16, 2008): 3338. http://dx.doi.org/10.1182/blood.v112.11.3338.3338.
Full textGuo, Feng, Peng Zhou, and Liang Ma. "TRAF3 Over-Expression Contributes to the Enhanced Alternative NF-κB Activity in Hodgkin's Lymphoma Cells." Blood 114, no. 22 (November 20, 2009): 3665. http://dx.doi.org/10.1182/blood.v114.22.3665.3665.
Full textMilhollen, Michael, Usha Narayanan, Allison J. Berger, Michael Thomas, Tary Traore, Jie Yu, Julie Zhang, et al. "MLN4924, a Novel Small Molecule Inhibitor of Nedd8-Activating Enzyme, Demonstrates Potent Anti-Tumor Activity in Diffuse Large B-Cell Lymphoma." Blood 112, no. 11 (November 16, 2008): 606. http://dx.doi.org/10.1182/blood.v112.11.606.606.
Full textKashyap, Trinayan, Boris Klebanov, Christian Argueta, Margaret S. Lee, Sharon Shacham, Michael Kauffman, Yosef Landesman, and William Senapedis. "Efficacy of Selinexor Is Dependent on IκB-α Expression and NF-Kb Deactivation in Multiple Myeloma Cells." Blood 128, no. 22 (December 2, 2016): 5660. http://dx.doi.org/10.1182/blood.v128.22.5660.5660.
Full textKagoya, Yuki, Akihide Yoshimi, Shunya Arai, Keisuke Kataoka, Masahiro Nakagawa, Keiki Kumano, and Mineo Kurokawa. "NF-κB/TNF-α Positive Feedback Loop with Active Proteasome Machinery Supports Myeloid Leukemia Initiating Cell Capacity." Blood 120, no. 21 (November 16, 2012): 654. http://dx.doi.org/10.1182/blood.v120.21.654.654.
Full textMessa, Emanuela, Ilaria Defilippi, Antonella Roetto, Francesca Messa, Francesca Arruga, Sonia Carturan, Valentina Rosso, Enrico Bracco, Daniela Cilloni, and Giuseppe Saglio. "Deferasirox Is the Only Iron Chelator Acting as a Potent NF-KB Inhibitor in Myelodysplastic Syndromes." Blood 112, no. 11 (November 16, 2008): 2671. http://dx.doi.org/10.1182/blood.v112.11.2671.2671.
Full textTimar, Botond, Amy Chadburn, Daniel Knowles, and Ethel Cesarman. "Activation of Classical and Alternative Nuclear Factor-kappaB (NF-kB) Pathways in Diffuse Large B-Cell Lymphomas." Blood 104, no. 11 (November 16, 2004): 29. http://dx.doi.org/10.1182/blood.v104.11.29.29.
Full textPham, Lan V., Archito Tamayo, Hai-Jun Zhou, Yen-Chiu Lin Lee, Lingchen Fu, Carlos E. Bueso-Ramos, Elias Drakos, L. Jeffrey Medeiros, and Richard J. Ford. "Networking Modules of Canonical and Alternative NFkB Signaling in Growth and Survival Regulations of Large B Cell Lymphomas." Blood 112, no. 11 (November 16, 2008): 3776. http://dx.doi.org/10.1182/blood.v112.11.3776.3776.
Full textTiedemann, Rodger E., Jonathan J. Keats, Jessica Schmidt, Chang-Xin Shi, Yuan X. Zhu, Xinliang Mao, Aaron D. Schimmer, and Keith Stewart. "Identification of a Potent Natural Triterpenoid Inhibitor of Proteosome Chymotrypsin-Like Activity and NF-κB with Specific Anti-Myeloma Activity in Vitro and in Vivo." Blood 112, no. 11 (November 16, 2008): 3679. http://dx.doi.org/10.1182/blood.v112.11.3679.3679.
Full textGuo, Feng, Zi-Xing Chen, Aining Sun, Peng Zhou, and Wenjuan Wang. "Differential Effects of TRAFs in the Activation of NF-KappB in Hodgkin’s Lymphoma Cells." Blood 112, no. 11 (November 16, 2008): 1458. http://dx.doi.org/10.1182/blood.v112.11.1458.1458.
Full textYang, Jun, Francis R. Leblanc, Shubha Dighe, Susan B. Nyland, David J. Feith, and Thomas P. Loughran. "Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Mediates and Sustains NF-κb Constitutive Activation in LGL Leukemia Cells." Blood 128, no. 22 (December 2, 2016): 2762. http://dx.doi.org/10.1182/blood.v128.22.2762.2762.
Full textHewamana, Saman, Clare Rowntree, Thet Thet Lin, Chris Pepper, Paul Brennan, and Chris Fegan. "Constitutive Nuclear p65 NF-kB Expression Predicts for Spontaneous Apoptosis and In Vitro Sensitivity to Fludarabine in CLL Cells." Blood 108, no. 11 (November 16, 2006): 4974. http://dx.doi.org/10.1182/blood.v108.11.4974.4974.
Full textCilloni, Daniela, Francesca Messa, Valentina Rosso, Sonia Carturan, Francesca Arruga, Ilaria Defilippi, Renata Catalano, et al. "NPM1 Mutations Are Responsible for Better Response to Induction Therapy in AML Patients through the Inactivation of NF-kB." Blood 106, no. 11 (November 16, 2005): 105. http://dx.doi.org/10.1182/blood.v106.11.105.105.
Full textIslam, Abul, Ken-ichiro Otsuyama, Jakia Amin, Saeid Abroun, Karim Shamsasenjan, Mohd S. Iqbal, and Michio M. Kawano. "SDF-1 Is Responsible for the Constitutively High NF-kB Activity in Human Myeloma Cells." Blood 110, no. 11 (November 16, 2007): 4737. http://dx.doi.org/10.1182/blood.v110.11.4737.4737.
Full textHillman, K., J. Qian, J. N. Siegel, G. Roderiquez, R. Blackburn, J. Manischewitz, M. Norcross, and H. Golding. "Reduced susceptibility to HIV-1 infection of ethyl-methanesulfonate-treated CEM subclones correlates with a blockade in their protein kinase C signaling pathway." Journal of Immunology 148, no. 12 (June 15, 1992): 3991–98. http://dx.doi.org/10.4049/jimmunol.148.12.3991.
Full textDickson, Kathleen M., Asha L. Bhakar, and Philip A. Barker. "TRAF6-dependent NF-kB transcriptional activity during mouse development." Developmental Dynamics 231, no. 1 (2004): 122–27. http://dx.doi.org/10.1002/dvdy.20110.
Full textPasqualucci, Laura, Mara Compagno, Wei Keat Lim, Adina Grunn, Subhadra V. Nandula, Marta Scandurra, Francesco Bertoni, et al. "Mutations in Multiple Genes Cause Deregulation of the NFkB Pathway in Diffuse Large B-Cell Lymphoma." Blood 112, no. 11 (November 16, 2008): 801. http://dx.doi.org/10.1182/blood.v112.11.801.801.
Full textMaeda, Yasuhiro, Terufumi Yamaguchi, Yasuki Hijikata, Yasuyoshi Morita, Chikara Hirase, Syunsuke Takai, Jun-ichi Miyatake, Mitsuhiro Matsuda, and Akihisa Kanamaru. "Dichotomy of All-Trans Retinoic Acid Inducing Signals for Adult T-Cell Leukemia." Blood 106, no. 11 (November 16, 2005): 4803. http://dx.doi.org/10.1182/blood.v106.11.4803.4803.
Full textTogano, Tomiteru, Makoto Nakashima, Mariko Watanabe, Kazuo Umezawa, Toshiki Watanabe, Masaaki Higashihara, and Ryouichi Horie. "Inhibition of NF-κB Activation Augments the Effect of 5-Azacytidine On Acute Myeloid Leukemia Cell Line." Blood 120, no. 21 (November 16, 2012): 1369. http://dx.doi.org/10.1182/blood.v120.21.1369.1369.
Full textStephenson, Diane, Tinggui Yin, E. Barry Smalstig, Mei Ann Hsu, Jill Panetta, Sheila Little, and James Clemens. "Transcription Factor Nuclear Factor-Kappa B is Activated in Neurons after Focal Cerebral Ischemia." Journal of Cerebral Blood Flow & Metabolism 20, no. 3 (March 2000): 592–603. http://dx.doi.org/10.1097/00004647-200003000-00017.
Full textOliveira, Vasco A., Linda Mathews, Danielle Yarde, Xingyu Wang, David Boulware, Lori A. Hazlehurst, Dung-Tsa Chen, Amer Beg, and William S. Dalton. "NF-kB as a Regulator of FA/BRCA Gene Expression in Multiple Myeloma." Blood 110, no. 11 (November 16, 2007): 3508. http://dx.doi.org/10.1182/blood.v110.11.3508.3508.
Full textKurniawan, Shahdevi Nandar, Muthia Marwah, Rodhiyan R, and Nanik S. "THE EFFECT OF 500 NM DOSAGE OF NIMODIPINE ON NRF2 AND NF-KB EXPRESSION IN NEURON CELL LINE CULTURE SH-SY5Y EXPOSED WITH CHRONIC HYPERGLYCEMIA." International Journal of Research -GRANTHAALAYAH 8, no. 2 (May 30, 2020): 235–42. http://dx.doi.org/10.29121/granthaalayah.v8.i2.2020.214.
Full textAllen, Kristi L., Mukesh K. Jain, and Keith R. McCrae. "Decreased Expression of KLF2 and KLF4 Induced by Antiphospholipid Antibodies Promotes NF-Kb-Mediated Endothelial Cell Activation and Is Modulated by CBP/p300." Blood 116, no. 21 (November 19, 2010): 4315. http://dx.doi.org/10.1182/blood.v116.21.4315.4315.
Full textHuang, Fei, Li-Yin Hung, and Reen Wu. "The differential roles of Act-1 and NF-κB in the regulation of various IL-17A-induced genes in A549 cells (134.95)." Journal of Immunology 182, no. 1_Supplement (April 1, 2009): 134.95. http://dx.doi.org/10.4049/jimmunol.182.supp.134.95.
Full textMorotti, Alessandro, Veronica Ullmannova, Daniela Cilloni, Francesca Messa, Manuela Messa, Ilaria Defilippi, Francesca Arruga, et al. "Over-Expression of the P65 Subunit of NF-kB and Increased DNA Binding Activity of NF-kB Is a Common Event Both in Philadelphia Positive and Negative Chronic Myeloproliferative Disorders." Blood 104, no. 11 (November 16, 2004): 4759. http://dx.doi.org/10.1182/blood.v104.11.4759.4759.
Full textGu, Lubing, Ningxi Zhu, Harry W. Findley, and Muxiang Zhou. "Loss of PTEN Expression Induces NF-kB Via PI3K/Akt Pathway Involving Resistance to Chemotherapy in Acute Lymphoblastic Leukemia Cell Lines." Blood 104, no. 11 (November 16, 2004): 4438. http://dx.doi.org/10.1182/blood.v104.11.4438.4438.
Full textQu, Changju, Yadong Liu, Kranthi Kunkalla, Nitin K. Agarwal, and Francisco Vega. "Smoothened (SMO) Activates NF-Kb Pathway Through Activation of PKCβ/CARMA1 and TRAF6 Stabilization in Diffuse Large B-Cell Lymphoma." Blood 120, no. 21 (November 16, 2012): 1298. http://dx.doi.org/10.1182/blood.v120.21.1298.1298.
Full textOJAYM, ALHUSSAIN A., Bing Yu, and Min-Ho Kim. "Fenton-catalytic nanocomposites for reprograming macrophages towards the improved anti-biofilm activity." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 86.9. http://dx.doi.org/10.4049/jimmunol.204.supp.86.9.
Full textGeng, Jian-Guo, Jian-Guo Wang, Nigel Mackman, Arne Slungaard, Yuqing Huo, and Nigel S. Key. "Regulation of Tissue Factor by NF-kB Transcription Factor p50 Is Essential for the Pathogeneses of Deep Vein Thrombosis and Arterial Restenosis." Blood 108, no. 11 (November 16, 2006): 1458. http://dx.doi.org/10.1182/blood.v108.11.1458.1458.
Full textHideshima, Teru, Noopur Raje, Ruben Carrasco, Hiroshi Ikeda, Yutaka Okawa, Tanyel Kiziltepe, Sonia Valet, et al. "Delineation of Canonical and Non-Canonical NF-κB Pathways in Multiple Myeloma: Therapeutic Implications." Blood 110, no. 11 (November 16, 2007): 670. http://dx.doi.org/10.1182/blood.v110.11.670.670.
Full textLenz, Georg, R. Eric Davis, Vu N. Ngo, Lloyd T. Lam, Thaddeus George, George W. Wright, Sandeep S. Dave, et al. "CARD11 as an Oncogene in Diffuse Large B Cell Lymphoma." Blood 110, no. 11 (November 16, 2007): 692. http://dx.doi.org/10.1182/blood.v110.11.692.692.
Full textPéant, B., J. Diallo, L. Lessard, A. Mes-Masson, and F. Saad. "Regulation of IKKe expression by androgen receptor and NF-kB transcriptional factor in prostate cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 10106. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10106.
Full textRoh, Eunmiri, Heun-Sik Lee, Jeong-Ah Kwak, Sang Hun Jung, Sang-Bae Han, and Youngsoo Kim. "Novel chalcone JSH 4-4 inhibit NF-kB-regulated inflammatory gene expression via targeting LPS-binding site of MD-2 (98.4)." Journal of Immunology 184, no. 1_Supplement (April 1, 2010): 98.4. http://dx.doi.org/10.4049/jimmunol.184.supp.98.4.
Full textArai, Ayako, Mayumi Takahashi, Ken-Ichi Imadome, Takatoshi Koyama, Yasunori Saitoh, Shoji Yamaoka, Shigeyoshi Fujiwara, and Osamu Miura. "NF-κB Is Constitutively Activated in EBV-Infected T or NK Cells and Can Be a Molecular Target for EBV-Positive T/NK-Cell Lymphoproliferative Disease Treatment." Blood 116, no. 21 (November 19, 2010): 1998. http://dx.doi.org/10.1182/blood.v116.21.1998.1998.
Full textYu, Hong-Nu, Young-Rae Lee, Hyun-Jaung Shim, Myung-Kwan Han, Eun-Kyung Song, Jinny Park, and Jong-Suk Kim. "Tumor Necrosis Factor-a Enhances Human Leukemia Cell Differentiation Induced by DMSO, but Not Retinoic Acid." Blood 106, no. 11 (November 16, 2005): 3893. http://dx.doi.org/10.1182/blood.v106.11.3893.3893.
Full textRadigina, T., A. Illarionov, D. Kuptsova, A. Potapov, S. Petrichuk, and A. P. Fisenko. "P423 NF-kB as a prognostic marker of response to biologic therapy in children with IBD." Journal of Crohn's and Colitis 14, Supplement_1 (January 2020): S386—S387. http://dx.doi.org/10.1093/ecco-jcc/jjz203.552.
Full textBaek, Suk-Hwan, Bin Huang, and Hyeun Wook Chang. "RNF144b is a negative regulator in TLR2-mediated NF-kB activation." Journal of Immunology 196, no. 1_Supplement (May 1, 2016): 132.4. http://dx.doi.org/10.4049/jimmunol.196.supp.132.4.
Full textCamara-Clayette, Valerie, Yves Lepelletier, Ivan Moura, William Vainchenker, Olivier Hermine, and Vincent Ribrag. "Canonical NF-kB Pathway Is Not Constitutively Activated and May Not Be the Major Bortezomib Target in Mantle Cell Lymphoma (MCL)." Blood 108, no. 11 (November 16, 2006): 2591. http://dx.doi.org/10.1182/blood.v108.11.2591.2591.
Full textSchrader, Carsten, Wolfram Klapper, Dirk Janssen, Paul Riis, Peter Meusers, Guenter Brittinger, Jens U. Siebmann, Michael Kneba, and Reza Parwaresch. "Analysis of Nuclear Factor Kappa B in Mantle Cell Lymphoma." Blood 106, no. 11 (November 16, 2005): 4712. http://dx.doi.org/10.1182/blood.v106.11.4712.4712.
Full textJain, H., N. Dhingra, T. Narsinghani, and R. Sharma. "Insights into the mechanism of natural terpenoids as NF-kB inhibitors: an overview on their anticancer potential." Experimental Oncology 38, no. 3 (September 22, 2016): 158–68. http://dx.doi.org/10.31768/2312-8852.2016.38(3):158-168.
Full text